Gene · 259
Papers2,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kidney stone matrix proteins: Role in stone formation. | World J Nephrol | 2023 | 37035509 | PubTator, text mining | PubMed |
Study protocol of a phase 2, randomised, placebo-controlled, double-blind, adaptive, parallel group clinical study to evaluate the efficacy and safety of recombinant alpha-1-microglobulin in subjects at high risk for acute kidney injury following open-chest cardiac surgery (AKITA trial). | BMJ Open | 2023 | 37024249 | PubTator, text mining | PubMed |
| Research progress on exosomes in podocyte injury associated with diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | 37020588 | PubTator, text mining | PubMed |
| Analytical characterization of host-cell-protein-rich aggregates in monoclonal antibody solutions. | Biotechnol Prog | 2023 | 37020359 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Probing multiple algorithms to calculate brain age: Examining reliability, relations with demographics, and predictive power. | Hum Brain Mapp | 2023 | 37017242 | PubTator, text mining | PubMed |
| Functional connectivity of the language area in migraine: a preliminary classification model. | BMC Neurol | 2023 | 37016325 | PubTator, text mining | PubMed |
| Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting. | Cancer Med | 2023 | 37014817 | PubTator, text mining | PubMed |
| Integrated proteome sequencing, bulk RNA sequencing and single-cell RNA sequencing to identify potential biomarkers in different grades of intervertebral disc degeneration. | Front Cell Dev Biol | 2023 | 37009470 | PubTator, text mining | PubMed |
| Hemolysis scavenger proteins and renal function marker in children with sickle cell disease at steady state: A cross-sectional study. | Health Sci Rep | 2023 | 37008811 | PubTator, text mining | PubMed |
| Protein phosphatase 2A propels follicular T helper cell development in lupus. | J Autoimmun | 2023 | 37001432 | PubTator, text mining | PubMed |
| Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response. | Mol Cells | 2023 | 36994475 | PubTator, text mining | PubMed |
| Associations of Urine Biomarkers of Kidney Tubule Health With Incident Hypertension and Longitudinal Blood Pressure Change in Middle-Aged Adults: The CARDIA Study. | Hypertension | 2023 | 36987923 | PubTator, text mining | PubMed |
| Catalytic Properties of Zirconocene-Based Systems in 1-Hexene Oligomerization and Structure of Metal Hydride Reaction Centers. | Molecules | 2023 | 36985393 | PubTator, text mining | PubMed |
| New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy. | Int J Mol Sci | 2023 | 36982164 | PubTator, text mining | PubMed |
| The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas. | Cancers (Basel) | 2023 | 36980534 | PubTator, text mining | PubMed |
| Proteomic Approaches and Potential Applications in Autosomal Dominant Polycystic Kidney Disease and Fabry Disease. | Diagnostics (Basel) | 2023 | 36980460 | PubTator, text mining | PubMed |
| LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1. | Biomolecules | 2023 | 36979356 | PubTator, text mining | PubMed |
| Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis. | Nat Commun | 2023 | 36973261 | PubTator, text mining | PubMed |
| The ABCG2 rs2231142 polymorphism and the risk of nephrolithiasis: A case-control study from the Taiwan biobank. | Front Endocrinol (Lausanne) | 2023 | 36967798 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/259/papers?page=13